Familial idiopathic intracranial hypertension and variegate porphyria-is there any connection?: Report of three sisters

References

• Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS, Hopson D. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982; 39: 461–474
   PubMedGoogle Scholar
• Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991; 114: 155–180
   PubMed Web of Science ®Google Scholar
• Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol 1988; 45: 866–872
   PubMed Web of Science ®Google Scholar
• Lessell S. Pediatric pseudotumor cerebri (Idiopathic intracranial hypertension). Surv Ophthalmol 1992; 37: 155–166
   PubMed Web of Science ®Google Scholar
• Joynt RJ, Sahs AL. Endocrine studies in pseudotumor cerebri. Trans Am Neurol Assoc 1962; 87: 110–113
   Google Scholar
• Reid AC, Thomson JA. Absence of significant endocrine deficiencies in benign intracranial hypertension. J Neurol Neurosurg Psychiat 1981; 44: 731–734
   PubMed Web of Science ®Google Scholar
• Sörensen PS, Gjerris F, Svenstrup B. Endocrine studies in patients with pseudotumor cerebri. Estrogen levels in blood and cerebrospinal fluid. Arch Neurol 1986; 43: 902–906
   PubMedGoogle Scholar
• Barber SG, Garvan N. Is 'benign intracranial hypertension' really benign?. J Neurol Neurosurg Psychiat 1980; 43: 136–138
   PubMedGoogle Scholar
• Jefferson A. A clinical correlation between encephalopathy and papill-oedema in Addison's disease. J Neurol Neurosurg Psychiat 1956; 19: 21–27
   PubMedGoogle Scholar
• Britton C, Boxhill C, Brust JCM, Healton EB, Braun CW, Killian P. Pseudotumor cerebri, empty sella syndrome, and adrenal adenoma. Neurology 1980; 30: 292–296
   PubMed Web of Science ®Google Scholar
• Donaldson JO, Binstock ML. Pseudotumor cerebri in an obese woman with Turner syndrome. Neurology 1981; 31: 758–760
   PubMedGoogle Scholar
• Sheldon RS, Becker WJ, Hanley DA, Culver RL. Hypoparathyroidism and pseudotumor cerebri: An infrequent clinical association. Can J Neurol Sci 1987; 14: 622–625
   PubMedGoogle Scholar
• Gökalp HZ, Baskaya MK, Aydin V. Pseudotumor cerebri with familial Mediterranean fever. Clin Neurol Neurosurg 1992; 94: 261–263
   PubMed Web of Science ®Google Scholar
• Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. The Metabolic Basis of Inherited Disease.6th edn., CR Scriver, AL Beaudet, WS Sly, D Valle. McGraw-Hill, New York 1989; 1305–1365
   Google Scholar
• Dean G. The Porphyrias. A Story of Inheritance and Environment.2d edn. Pitman Medical, London 1971; 176
   Google Scholar
• Eales L, Day RS, Blekkenhorst GH. The clinical and biochemical features of variegate porphyria: an analysis of 300 cases studied at Groote Schuur Hospital, Cape Town. Int J Biochem 1980; 12: 837–853
   PubMedGoogle Scholar
• Mustajoki P. Variegate porphyria. Twelve years' experience in Finland. Q J Med 1980; 49(N.S.)191–203
   PubMedGoogle Scholar
• Wetterberg L. A Neuropsychiatric and Genetical Investigation of Acute Intermittent Porphyria. Thesis, Norstedts, Stockholm 1967; 87
   Google Scholar
• Waldenström J. The porphyrias as inborn errors of metabolism. Am J Med 1957; 22: 758–773
   PubMed Web of Science ®Google Scholar
• Goldberg A. Acute intermittent porphyria. A study of 50 cases. Q J Med 1959; 28(N.S.)183–209
   PubMedGoogle Scholar
• Eales L, Linder GC. Porphyria-the acute attack. An analysis of 80 cases. S Afr Med J 1962; 36: 284–292
   PubMedGoogle Scholar
• Kauppinen R, Mustajoki P. Prognosis of acute porphyria: Occurrence of acute attacks, precipitating factors, and associated diseases. Medicine 1992; 71: 1–13
   PubMed Web of Science ®Google Scholar
• Waldenström J. Studien über Porphyrie. Thesis, Acta Med Scand. 1937; 82: 254, suppl
   Google Scholar
• Waldenström J. Neurological symptoms caused by socalled acute porphyria. Acta Psychiat Neurol 1939; 14: 375–379
   Google Scholar
• Martin WJ, Heck FJ. The porphyrins and porphyria. A review of eighty-one cases. Am J Med 1956; 20: 239–250
   PubMedGoogle Scholar
• Stein JA, Tschudy DP. Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Medicine 1970; 49: 1–16
   PubMed Web of Science ®Google Scholar
• Goldstein NP, Martin WJ, Brunsting LA, Kirby TJ. Blindness of cerebral origin in porphyria: report of a case. Proc Staff Meet Mayo Clin 1957; 32: 82–88
   PubMedGoogle Scholar
• Waldenström J. Some observations on acute porphyria and other conditions with a change in the excretion of porphyrins. Acta Med Scand 1934; 83: 281–316
   Google Scholar
• Lai CW, Hung T, Lin WSJ. Blindness of cerebral origin in acute intermittent porphyria. Report of a case and postmortem examination. Arch Neurol 1977; 34: 310–312
   PubMedGoogle Scholar
• Watson CJ. Porphyria. A Textbook of Medicine, 7th edn, RL Cecil. Saunders, Philadelphia, London 1948; 734–738
   Google Scholar
• Jaffe NS. Acute porphyria associated with retinal hemorrhages and bilateral oculomotor nerve palsy. Am J Ophthalmol 1950; 33: 470–472
   Google Scholar
• Ten Eyck FW, Martin WJ, Kernohan JW. Acute porphyria: Necropsy studies in nine cases. Proc Mayo Clin 1961; 36: 409–422
   PubMedGoogle Scholar
• Tan E, Kansu T, Zileli T. Severe ptosis without ophthalmoplegia due to porphyric neuropathy. Clin Neurol Neurosurg 1990; 92: 287–288
   PubMedGoogle Scholar
• Naef RW, Berry RG, Schlezinger NS. Neurologic aspects of porphyria. Neurology 1959; 9: 313–320
   PubMedGoogle Scholar
• Harris W. Toxic polyneuritis. Brain 1922; 45: 415–433
   Google Scholar
• Lyons HA. Acute porphyria with spinal fluid changes. Ann Int Med 1950; 33: 711–717
   PubMedGoogle Scholar
• DeFrancisco M, Savino PJ, Schatz NJ. Optic atrophy in acute intermittent porphyria. Am J Ophthalmol 1979; 87: 221–224
   PubMedGoogle Scholar
• Buchheit WA, Burton C, Haag B, Shaw D. Papilledema and idiopathic intracranial hypertension. Report of a familial occurrence. N Engl J Med 1969; 280: 938–942
   PubMed Web of Science ®Google Scholar
• Howe JG, Saunders M, Clarke PRR. Familial benign intracranial hypertension. Acta Neurochirurgica (Wien) 1973; 173–175
   Google Scholar
• Wells CEC. 39, Personal communication to Howe et al.
   Google Scholar
• Venable HP. Pseudo-tumor cerebri: further studies. J Natl Med Assoc NY 1973; 65: 194–197
   PubMedGoogle Scholar
• Rothner AD, Brust JCM. Pseudotumor cerebri. Report of a familial occurrence. Arch Neurol 1974; 30: 110–111
   PubMedGoogle Scholar
• Traviesa DC, Schwartzman RJ, Glaser JS, Savino P. Familial benign intracranial hypertension. J Neurol Neurosurg Psychiat 1976; 39: 420–423
   PubMedGoogle Scholar
• Rush JA. Pseudotumor cerebri. Clinical profile and visual outcome in 63 patients. Mayo Clin Proc 1980; 55: 541–546
   PubMed Web of Science ®Google Scholar
• Shapiro I, Shapiro SK. Familial pseudotumor cerebri and the empty sella syndrome. Ann Ophthalmol 1980; 12: 1045–1048
   PubMedGoogle Scholar
• Coffey CE, Ross DR, Massey EW, Olanow CW. Familial benign intracranial hypertension and depression. Can J Neurol Sci 1982; 9: 45–47
   PubMedGoogle Scholar
• Torlai F, Galassi G, Debbia A, Crisi G, Peduzzi M. Familial pseudotumor cerebri in male heterozygous twins. Eur Neurol 1989; 29: 106–108
   PubMedGoogle Scholar
• Johnston I, Morgan MK. A familial coincidence of pseudotumor cerebri and communicating hydrocephalus. Neurosurgery 1991; 28: 727–729
   PubMedGoogle Scholar
• Kharode C, McAbee G, Sherman J, Kaufman M. Familial intracranial hypertension: Report of a case and review of the literature. J Child Neurol 1992; 7: 196–198
   PubMedGoogle Scholar
• Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988; 45: 875–877
   PubMed Web of Science ®Google Scholar
• Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci 1993; 116: 18–28
   PubMed Web of Science ®Google Scholar
• Thompson MW, McInnes RR, Willard HF. Genetics in Medicine, 5th edn. Saunders, Philadelphia 1991; 500
   Google Scholar
• Dandy WE. Intracranial pressure without brain tumor. Diagnosis and treatment. Ann Surg 1937; 106: 492–513
   PubMedGoogle Scholar
• Lipton HL, Michelson PE. Pseudotumor cerebri syndrome without papilledema. JAMA 1972; 220: 1591–1592
   PubMed Web of Science ®Google Scholar
• Scanarini M, Mingrino S, D'Avella D, Delia Corte V. Benign intracranial hypertension without papilledema: Case report. Neurosurgery 1979; 5: 376–377
   PubMed Web of Science ®Google Scholar
• Spence JD, Amacher AL, Willis NR. Benign intracranial hypertension without papilledema: Role of 24-hour cerebrospinal fluid pressure monitoring in diagnosis and management. Neurosurgery 1980; 7: 326–336
   PubMed Web of Science ®Google Scholar
• Johnston I, Hawke S, Halmagyi M., Teo C. The pseudotumor syndrome. Disorders of cerebrospinal fluid circulation causing intracranial hypertension without ventriculome-galy. Arch Neurol 1991; 48: 740–747
   PubMedGoogle Scholar
• McKusick VA. Mendelian Inheritance in Man. Catalogs of Autosomal Dominant, Autosomal Recessive, and X-linked Phenotypes, 10th edn. Johns Hopkins University Press, Baltimore, London 1992; Vol. 1: 780
   Google Scholar
• Lysak WR, Svien HJ. Long-term follow-up on patients with diagnosis of pseudotumor cerebri. J Neurosurg 1966; 25: 284–287
   PubMed Web of Science ®Google Scholar
• Boddie HG, Banna M, Bradley WG. 'Benign' intracranial hypertension. A survey of the clinical and radiological features, and long-term prognosis. Brain 1974; 97: 313–326
   PubMedGoogle Scholar
• Gücer G, Viernstein L. Long-term intracranial pressure recording in the management of pseudotumor cerebri. J Neurosurg 1978; 49: 256–263
   PubMed Web of Science ®Google Scholar
• Bulens C, De Vries WAEJ, van Cre-Vel H. Benign intracranial hypertension. A retrospective and follow-up study. J Neurol Sci 1979; 40: 147–157
   PubMed Web of Science ®Google Scholar
• Digre KB, Varner MW, Corbett JJ. Pseudotumor cerebri and pregnancy. Neurology 1984; 34: 721–729
   PubMed Web of Science ®Google Scholar
• Foley KM. Is benign intracranial hypertension a chronic disease? (abstract.). Neurology 1977; 27: 388
   Google Scholar
• Repka MX, Miller NR, Savino PJ. Pseudotumor cerebri. Am J Ophthalmol 1984; 98: 741–746
   PubMed Web of Science ®Google Scholar
• Malm J, Kristensen B, Markgren P, Eksted J. CSF hydrodynamics in idiopathic intracranial hypertension: A long-term study. Neurology 1992; 42: 851–858
   PubMed Web of Science ®Google Scholar
• Ahlskog JE, O'Neill BP. Pseudotumor cerebri. Ann Int Med 1982; 97: 249–256
   PubMed Web of Science ®Google Scholar
• Lombaert A, Carton H. Benign intracranial hypertension due to A-hypervitaminosis in adults and adolescents. A review. Eur Neurol 1976; 14: 340–350
   PubMed Web of Science ®Google Scholar
• Walker AE, Adamkiewicz JJ. Pseudotumor cerebri associated with prolonged corticosteroid therapy. Reports of four cases. JAMA 1964; 188: 779–784
   PubMed Web of Science ®Google Scholar
• Ireland B, Corbett JJ, Wallace RB. The search for causes of idiopathic intracranial hypertension. A preliminary case-control study. Arch Neurol 1990; 47: 315–320
   PubMed Web of Science ®Google Scholar
• Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): A case-control study. Neurology 1991; 41: 239–244
   PubMed Web of Science ®Google Scholar
• Griffin JP. A review of the literature on benign intracranial hypertension associated with medication. Adverse Drug React. Toxicol Rev 1992; 11: 41–58
   Google Scholar
• Sahs AL, Joynt RJ. Brain swelling of unknown cause. Neurology 1956; 6: 791–803
   Web of Science ®Google Scholar
• Moser FG, Hilal SK, Abrams G, Bello JA, Schipper H, Silver AJ. MR imaging of pseudotumor cerebri. Am J Roentgenol 1988; 150: 903–909
   PubMedGoogle Scholar
• Silbergleit R, Junck L, Gebarski SS, Hatfield MK. Idiopathic intracranial hypertension (pseudotumor cerebri): MR imaging. Radiology 1989; 170: 207–209
   PubMedGoogle Scholar
• Connolly MB, Farrell K, Hill A., Flodmark O. Magnetic resonance imaging in pseudotumor cerebri. Dev Med Child Neurol 1992; 34: 1091–1094
   PubMedGoogle Scholar
• Bercaw BL, Greer M. Transport of intrathecal 131I RISA in benign intracranial hypertension. Neurology 1970; 20: 787–790
   PubMed Web of Science ®Google Scholar
• Calabrese VP, Selhorst JB, Harbison JW. CSF infusion test in pseudotumor cerebri. Trans Am Neurol Soc 1978; 103: 146–150
   PubMedGoogle Scholar
• Mann JD, Johnson RN, Butler AB, Bass NH. Impairment of cerebrospinal fluid circulatory dynamics in pseudotumor cerebri and response to steroid treatment (abstract). Neurology 1979; 29: 550
   Web of Science ®Google Scholar
• Janny P, Chazal J. Colnet G, Irthum B, Georget A-M. Benign intracranial hypertension and disorders of CSF absorption. Surg Neurol 1981; 15: 168–174
   PubMedGoogle Scholar
• Gjerris F, Sörensen PS, Vorstrup S, Paulson OB. Intracranial pressure, conductance to cerebrospinal fluid outflow, and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri). Ann Neurol 1985; 17: 158–162
   PubMed Web of Science ®Google Scholar
• Sörensen PS, Thomsen C, Gjerris F, Schmidt J, Kjaer L, Henriksen O. Increased brain water content in pseudotumor cerebri measured by magnetic resonance imaging of brain water self diffusion. Neurol Res 1989; 11: 160–164
   PubMedGoogle Scholar
• King PH, Bragdon AC. MRI reveals multiple reversible cerebral lesions in an attack of acute intermittent porphyria. Neurology 1991; 41: 1300–1302
   PubMed Web of Science ®Google Scholar
• Round R, Keane JR. The minor symtoms of increased intracranial pressure: 101 patients with benign intracranial hypertension. Neurology 1988; 38: 1461–1464
   PubMed Web of Science ®Google Scholar